Determination of the molecular basis of Marfan syndrome: a growth industry
- PMID: 15254580
- PMCID: PMC449756
- DOI: 10.1172/JCI22399
Determination of the molecular basis of Marfan syndrome: a growth industry
Abstract
Although it has been known for more than a decade that Marfan syndrome - a dominantly inherited connective tissue disorder characterized by tall stature, arachnodactyly, lens subluxation, and a high risk of aortic aneurysm and dissection - results from mutations in the FBN1 gene, which encodes fibrillin-1, the precise mechanism by which the pleiotropic phenotype is produced has been unclear. A report in this issue now proposes that loss of fibrillin-1 protein by any of several mechanisms and the subsequent effect on the pool of TGF-beta may be more relevant in the development of Marfan syndrome than mechanisms previously proposed in a dominant-negative disease model. The model proposed in this issue demonstrates several strategies for clinical intervention.
Figures
Comment on
-
Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.J Clin Invest. 2004 Jul;114(2):172-81. doi: 10.1172/JCI20641. J Clin Invest. 2004. PMID: 15254584 Free PMC article.
References
-
- Dietz HC, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–339. - PubMed
-
- Hollister DW, Godfrey M, Sakai LY, Pyeritz RE. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N. Engl. J. Med. 1990;323:152–159. - PubMed
-
- Lee B, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352:330–334. - PubMed
-
- Magenis RE, Maslen CL, Smith L, Allen L, Sakai LY. Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. Genomics. 1991;11:346–351. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
